SCHEMBL989956

SCHEMBL989956

O=Cc1cccc(O)c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC28A3 Q9HAS3 2/20 0.58
HIF1A Q16665 1/20 0.54
TYR P14679 3/20 0.51
EPHX2 P34913 2/20 0.49
SLC5A1 P13866 1/20 0.49
ALDH1A1 P00352 4/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 3/20 0.46
CASP1 P29466 3/20 0.46
CASP7 P55210 3/20 0.46
HSD17B10 Q99714 3/20 0.46
GLA P06280 2/20 0.46
GAA P10253 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29078207 0.85 SLC28A3 (0.64) SLC28A3HIF1ATYREPHX2SLC5A1
SCHEMBL1707950 0.85 TYR (0.51) SLC28A3HIF1ATYREPHX2ALDH1A1
SCHEMBL9563927 0.82 ALDH1A1 (0.47) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL987304 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL1006709 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL988045 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL9844557 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL9888348 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL20723406 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1
Helicin SCHEMBL9844555 0.82 SLC5A2 (0.57) SLC28A3HIF1ATYREPHX2SLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2271350-A1 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY Cognate3, LLC. (US) 2011-01-12 EP disclosed
WO-2009145841-A1 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY COGNATE 3, LLC (US) 2009-12-03 WO disclosed